Cartelma-AM Tablet is a pharmaceutical formulation that combines two active ingredients, Telmisartan and Amlodipine besylate, in a single medication. This tablet is used to manage hypertension (high blood pressure), a condition that can lead to serious health problems if left uncontrolled.
Telmisartan is an angiotensin II receptor blocker (ARB). It works by blocking the action of a hormone called angiotensin II, which causes blood vessels to constrict. By inhibiting angiotensin II, Telmisartan helps to relax and dilate blood vessels, reducing blood pressure and improving blood flow. This can ultimately reduce the workload on the heart and lower the risk of cardiovascular events.
Amlodipine besylate is a calcium channel blocker (CCB). It functions by preventing calcium from entering the cells of the heart and blood vessels. This results in relaxed blood vessels and reduced strain on the heart, leading to lowered blood pressure.
Combining Telmisartan and Amlodipine besylate in Cartelma-AM Tablet provides a synergistic effect, effectively controlling blood pressure through two different mechanisms. This combination therapy is particularly beneficial for individuals with hypertension that is not adequately managed by a single medication alone.Indications
Hypertension (High Blood Pressure)
Hypertension with Multiple Risk Factors
Hypertension with Target Organ Damage
